Open AccessProstate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome
Author(s) -
Riccardo Selice,
Nicola Caretta,
Antonella Di Mambro,
M Torino,
Pierfrancesco Palego,
Alberto Ferlin,
Carlo Foresta
Publication year - 2013
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-13-0488
Subject(s) - medicine , endocrinology , prostate , testosterone (patch) , insulin resistance , metabolic syndrome , prostate cancer , klinefelter syndrome , obesity , hormone replacement therapy (female to male) , waist , cancer
Klinefelter syndrome (KS) is a chromosomal alteration characterized by increased risk of metabolic syndrome, mainly caused by visceral obesity. In the last years, obesity has been studied as a potential risk factor for prostate disease and recently a link has been demonstrated between visceral adiposity with prostate volume. The aim of this study was to analyze the relationship between obesity and prostate volume and growth during testosterone therapy in KS subjects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom